JP2024531607A5 - - Google Patents
Info
- Publication number
- JP2024531607A5 JP2024531607A5 JP2024515064A JP2024515064A JP2024531607A5 JP 2024531607 A5 JP2024531607 A5 JP 2024531607A5 JP 2024515064 A JP2024515064 A JP 2024515064A JP 2024515064 A JP2024515064 A JP 2024515064A JP 2024531607 A5 JP2024531607 A5 JP 2024531607A5
- Authority
- JP
- Japan
- Prior art keywords
- modification
- mutant polypeptide
- nucleic acid
- modification includes
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163241821P | 2021-09-08 | 2021-09-08 | |
| US63/241,821 | 2021-09-08 | ||
| US202263296741P | 2022-01-05 | 2022-01-05 | |
| US63/296,741 | 2022-01-05 | ||
| PCT/US2022/076112 WO2023039472A2 (en) | 2021-09-08 | 2022-09-08 | Compositions comprising a crispr nuclease and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024531607A JP2024531607A (ja) | 2024-08-29 |
| JP2024531607A5 true JP2024531607A5 (enExample) | 2025-09-16 |
Family
ID=85506919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024515064A Pending JP2024531607A (ja) | 2021-09-08 | 2022-09-08 | Ｃｒｉｓｐｒヌクレアーゼを含む組成物及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US12344870B2 (enExample) |
| EP (1) | EP4399310A4 (enExample) |
| JP (1) | JP2024531607A (enExample) |
| AU (1) | AU2022344256A1 (enExample) |
| CA (1) | CA3230609A1 (enExample) |
| TW (1) | TW202321447A (enExample) |
| WO (1) | WO2023039472A2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2022344256A1 (en) | 2021-09-08 | 2024-02-29 | Arbor Biotechnologies, Inc. | Compositions comprising a crispr nuclease and uses thereof |
| KR20250151430A (ko) | 2023-02-15 | 2025-10-21 | 아버 바이오테크놀로지스, 인크. | 스타스민 2(stmn2) 전사체에서 비정상적인 스플라이싱을 억제하는 유전자 편집 방법 |
| WO2025171210A1 (en) | 2024-02-09 | 2025-08-14 | Arbor Biotechnologies, Inc. | Compositions and methods for gene editing via homology-mediated end joining |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013266968B2 (en) | 2012-05-25 | 2017-06-29 | Emmanuelle CHARPENTIER | Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription |
| EP3500967A1 (en) | 2016-08-17 | 2019-06-26 | The Broad Institute, Inc. | Methods for identifying class 2 crispr-cas systems |
| WO2019178427A1 (en) * | 2018-03-14 | 2019-09-19 | Arbor Biotechnologies, Inc. | Novel crispr dna targeting enzymes and systems |
| WO2020018142A1 (en) * | 2018-07-16 | 2020-01-23 | Arbor Biotechnologies, Inc. | Novel crispr dna targeting enzymes and systems |
| US20220049273A1 (en) | 2019-03-01 | 2022-02-17 | Arbor Biotechnologies, Inc. | Novel crispr dna targeting enzymes and systems |
| MX2022004549A (es) * | 2019-10-17 | 2022-07-21 | Pairwise Plants Services Inc | Variantes de nucleasas cas12a, metodos de fabricacion y uso de las mismas. |
| JP2023505234A (ja) * | 2019-12-04 | 2023-02-08 | アーバー バイオテクノロジーズ， インコーポレイテッド | ヌクレアーゼを含む組成物及びその使用 |
| AU2022344256A1 (en) | 2021-09-08 | 2024-02-29 | Arbor Biotechnologies, Inc. | Compositions comprising a crispr nuclease and uses thereof |
-
2022
- 2022-09-08 AU AU2022344256A patent/AU2022344256A1/en active Pending
- 2022-09-08 TW TW111134168A patent/TW202321447A/zh unknown
- 2022-09-08 US US17/930,595 patent/US12344870B2/en active Active
- 2022-09-08 JP JP2024515064A patent/JP2024531607A/ja active Pending
- 2022-09-08 CA CA3230609A patent/CA3230609A1/en active Pending
- 2022-09-08 WO PCT/US2022/076112 patent/WO2023039472A2/en not_active Ceased
- 2022-09-08 EP EP22868305.8A patent/EP4399310A4/en active Pending
-
2025
- 2025-05-30 US US19/223,291 patent/US20250290053A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7700079B2 (ja) | ゲノム編集のためのシステム及び方法 | |
| US10781432B1 (en) | Engineered cascade components and cascade complexes | |
| JP2024531607A5 (enExample) | ||
| JP2022516130A5 (enExample) | ||
| JP2023517294A5 (enExample) | ||
| CN113373130A (zh) | Cas12蛋白、含有Cas12蛋白的基因编辑系统及应用 | |
| JP2023541400A5 (enExample) | ||
| JP2021522783A5 (enExample) | ||
| CN111902536A (zh) | 用于真核基因组修饰的改造的cas9系统 | |
| JP2022540153A5 (enExample) | ||
| CN109929839A (zh) | 拆分型单碱基基因编辑系统及其应用 | |
| JP2023504826A5 (enExample) | ||
| WO2020032057A1 (en) | Novel transcription activator | |
| KR102151064B1 (ko) | 매칭된 5' 뉴클레오타이드를 포함하는 가이드 rna를 포함하는 유전자 교정용 조성물 및 이를 이용한 유전자 교정 방법 | |
| CN106459940B (zh) | 新型过氧化氢酶信号序列及利用其的过氧化氢酶表达方法 | |
| CN119685290A (zh) | 一种用于引导编辑技术的组合物和方法 | |
| CN118086340A (zh) | 微型碱基编辑器及其构建方法与应用 | |
| WO2026067648A1 (en) | Type ii cas protein and uses thereof | |
| CN113652411A (zh) | Cas9蛋白、含有Cas9蛋白的基因编辑系统及应用 | |
| RU2800921C2 (ru) | Новый активатор транскрипции | |
| HK40121254A (zh) | 一种cas12蛋白及其应用 | |
| CN121780484A (zh) | CRISPR-Cas12b2基因编辑系统及其应用 | |
| CN121653099A (zh) | 一种工程化的核酸酶及其应用 | |
| US20140065699A1 (en) | Novel bacterial expression plasmid | |
| Lee et al. | Tandem Promoters for Expression of Cnu, a Nucleoid Protein, in Escherichia coli. |